Fragment-based QSAR strategies in drug design
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery
Link
http://www.tandfonline.com/doi/pdf/10.1517/17460441003782277
Reference30 articles.
1. A brief history of novel drug discovery technologies
2. Virtual Screening and Its Integration with Modern Drug Design Technologies
3. A decade of fragment-based drug design: strategic advances and lessons learned
4. Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. QSAR Modeling Using Molecular Fragment Descriptors;Synthesis Lectures on Mathematics & Statistics;2024-09-03
2. Evaluating the Therapeutic Potential of Curcumin and Synthetic Derivatives: A Computational Approach to Anti-Obesity Treatments;International Journal of Molecular Sciences;2024-02-23
3. Design and Evaluation of Synthesized Pyrrole Derivatives as Dual COX-1 and COX-2 Inhibitors Using FB-QSAR Approach;ACS Omega;2023-12-12
4. Toward Application and Implementation of in Silico Tools and Workflows within Benign by Design Approaches;ACS Sustainable Chemistry & Engineering;2021-08-31
5. QSAR Study of Thieno [2,3-d] Pyrimidine as a Promising Scaffold Using HQSAR, CoMFA and CoMSIA;CHINESE J STRUC CHEM;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3